Need al­ter­na­tive fund­ing chan­nels? Per­cep­tive Ad­vi­sors now has $675M de­vot­ed to those deals

The glob­al tide of cap­i­tal gush­ing in­to bio­phar­ma isn’t just go­ing through tra­di­tion­al ven­ture funds. As Per­cep­tive Ad­vi­sors is show­ing with their $675 mil­lion fund …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.